5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial

The Lancet 2026

View at publisher
Authors: Sofia Rivera, Robabeh Ghodssighassemabadi, Guillaume Auzac, Thomas Brion, Youlia Kirova, S. Racadot, M. Benchalal, Jean-Baptiste Clavier, C. Brunaud, Anaïs Groulier, Delphine Argo-Leignel, Karine Peignaux
+27 more Ahmed Benyoucef, D. Pasquier, Philippe Guilbert, Aurore Goineau, Agnes Tallet, Marie Bergeaud, Assia Lamrani-Ghaouti, Stefan Michiels, J. Blanchecotte, Adeline Petit, G. Bernadou, Xavier Zasadny, C. Lemanski, J. Fourquet, Emmanuelle Malaurie, H. Kouto, Carole Massabeau, Alexandre Henni, Pauline Regnault, A. Bellière, Yazid Belkacemi, Magali Le Blanc‐Onfroy, Julien Geffrelot, Jean-Briac Prevost, Stephanie Wong, Claire Petit, Amandine Ruffier
DOI: 10.1016/s0140-6736(25)02597-8
Cited by: 5
References: 34

Fields of Study & Subjects

Breast Cancer Treatment Studies Breast Lesions and Carcinomas Medical Imaging Techniques and Applications

Publication details

Journal / source
The Lancet
Publisher
Elsevier BV
Volume
407
Issue
10532
Pages
976–987
Publication date
1 March 2026
Language
EN